Literature DB >> 16432953

A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. 2004.

Pirow J Bekker, Donna L Holloway, Amy S Rasmussen, Robyn Murphy, Steven W Martin, Philip T Leese, Gregory B Holmes, Colin R Dunstan, Alex M DePaoli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16432953     DOI： 10.1359/jbmr.2005.20.12.2274

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  16 in total

1.  Strategies of spinal fusion on osteoporotic spine.

Authors:  Sung Bae Park; Chun Kee Chung
Journal:  J Korean Neurosurg Soc       Date:  2011-06-30

Review 2.  Integration of denosumab therapy in the management of giant cell tumors of bone.

Authors:  Daniel T Miles; Ryan T Voskuil; Wood Dale; Joel L Mayerson; Thomas J Scharschmidt
Journal:  J Orthop       Date:  2020-03-28

3.  RANK, RANKL and OPG Expression in Breast Cancer - Influence on Osseous Metastasis.

Authors:  J T Ney; T Fehm; I Juhasz-Boess; E F Solomayer
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-05       Impact factor: 2.915

4.  Zoledronate but not denosumab suppresses macrophagic differentiation of THP-1 cells. An aetiologic model of bisphosphonate-related osteonecrosis of the jaw (BRONJ).

Authors:  Sebastian Hoefert; Claudia Sade Hoefert; Marc Albert; Adelheid Munz; Martin Grimm; Hinnak Northoff; Siegmar Reinert; Dorothea Alexander
Journal:  Clin Oral Investig       Date:  2014-11-21       Impact factor: 3.573

Review 5.  An antibody against RANKL for the treatment of osteoporosis, inflammatory and malignant bone diseases.

Authors:  Eduardo Maldonado-Gonzales; Peter Pietschmann
Journal:  Wien Med Wochenschr       Date:  2010-08-16

Review 6.  Denosumab.

Authors:  Steven C Pageau
Journal:  MAbs       Date:  2009-05-29       Impact factor: 5.857

7.  A single-nucleotide polymorphism in the gene encoding osteoprotegerin, an anti-inflammatory protein produced in response to infection with diarrheagenic Escherichia coli, is associated with an increased risk of nonsecretory bacterial diarrhea in North American travelers to Mexico.

Authors:  Jamal A Mohamed; Herbert L DuPont; Zhi-Dong Jiang; Jose Flores; Lily G Carlin; Jaime Belkind-Gerson; Francisco G Martinez-Sandoval; Dongchuan Guo; A Clinton White; Pablo C Okhuysen
Journal:  J Infect Dis       Date:  2009-02-15       Impact factor: 5.226

8.  The central role of wear debris in periprosthetic osteolysis.

Authors:  P Edward Purdue; Panagiotis Koulouvaris; Bryan J Nestor; Thomas P Sculco
Journal:  HSS J       Date:  2006-09

Review 9.  Bone mineral density in patients on maintenance dialysis.

Authors:  Csaba Ambrus; Adrienn Marton; Zsofia Klara Nemeth; Istvan Mucsi
Journal:  Int Urol Nephrol       Date:  2009-12-29       Impact factor: 2.370

Review 10.  Comparative effects of antiresorptive agents on bone mineral density and bone turnover in postmenopausal women.

Authors:  Natasha Jordan; Maurice Barry; Eithne Murphy
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.